VALIDATION OF THE APIXABAN COST-EFFECTIVENESS MODEL IN PATIENTS WITH VENOUS THROMBOEMBOLISM

Background: To assess the predictive validity of apixaban cost-effectiveness model by comparing key event rates from model to those seen in AMPLIFY and AMPLIFY-EXT trials in patients with venous thromboembolism (VTE).

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the American College of Cardiology 2015-03, Vol.65 (10), p.A2087-A2087
Hauptverfasser:	Lanitis, Tereza, Hamilton, Melissa, Rublee, Dale, Browne, Chantelle, Leipold, Robert, Quon, Peter, Masseria, Cristina, Cohen, Alexander
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiology Cardiovascular Drug therapy Heart attacks Internal Medicine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!